Description

8-Bromo-9-β-D-Xylofuranosyladenine is a modified nucleoside analog of significant interest in pharmaceutical research and development. This compound serves as a crucial synthetic intermediate and a versatile building block for the creation of novel therapeutic agents. It is primarily utilized by research institutions and pharmaceutical companies engaged in the synthesis of antiviral drugs, anticancer compounds, and other nucleoside-based pharmaceuticals.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel antiviral and anticancer nucleoside analogs.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies to investigate nucleoside metabolism and related pathways.
• Medicinal Chemistry: Serves as a versatile scaffold for structure-activity relationship (SAR) studies to optimize drug potency and selectivity.
• Antiviral Agent Development: Explored for its potential activity against a range of viral targets due to its modified nucleoside structure.
• Labeled Compound Synthesis: Can be used as a starting material for the preparation of radiolabeled or fluorescently tagged probes for diagnostic and research applications.
• Academic & Industrial R&D: Employed in discovery programs focused on nucleotide-targeting therapies.

Basic Information

Product Name	8-Bromo-9-β-D-Xylofuranosyladenine
CAS No.	15830-78-1
Molecular Formula	C₁₀H₁₂BrN₅O₄
Molecular Weight	346.14 g/mol
Synonyms	8-Bromoadenosine xylofuranoside; 8-Bromo-9-β-D-xylofuranosyladenine; 8-Bromoxylofuranosyladenine; 8-Br-xylofuranosyladenine; 8-Bromo-9-(β-D-xylofuranosyl)adenine; Adenine, 8-bromo-9-β-D-xylofuranosyl-; 8-Bromo-9-(β-D-xylofuranosyl)-9H-purin-6-amine
EINECS	Contact for details

Quality Control

Our 8-Bromo-9-β-D-Xylofuranosyladenine is manufactured under strict quality control protocols to ensure high purity and batch-to-batch consistency, suitable for demanding research and development applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP principles where applicable to support our clients' regulatory and quality assurance requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/IR)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.